hotspot -WSS

hotspot

author：fashion 2025-08-27 16:47:25 - browse：7

Beam Therapeutics said Thursday morning it would lay off 20% of its staff — or around 100 employees — and pause or reevaluate certain programs as it looks to cut costs.

It’s a notable setback for a gene-editing company that quickly raised over $1 billion in the few years after its co-founder, David Liu, described a new form of CRISPR, called base editing, that allowed researchers to change individual letters of DNA. The biotech hired rapidly, announced its intention to treat a broad range of diseases, and received clearance to start clinical trials in cancer and sickle cell.

Beam, however, has struggled to enroll patients in those trials. Meanwhile, the biotech stock market has stayed cold, including for gene-editing companies, whose technologies raise new regulatory, safety, and reimbursement questions. The pending approval of two gene therapies for sickle cell would also limit the market for Beam’s lead drug.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Supreme Court strikes down use of affirmative action
Next article： Intarcia’s device

WSS

How AI helped researchers track recovery from depression

The PBM ad wars are taking over Washington, D.C.

Intarcia’s device

California man arrested in connection with serial murders of Mexican strip club workers

Why are Kaiser Permanente staff considering a strike?

Sen. Bill Cassidy on how to lower drug prices

hotspot

hotspot

focus

Medical leaders decry Supreme Court decision on affirmative action

Ahead of NATO summit, Biden meets with King Charles for 1st time since coronation

Wildfire smoke exposes gaps in outdoor worker protections

Biotech stock slump in 2023: awaiting the turnaround

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Lasker Awards 2023: Winners in biomedical research

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

What to know about a major upcoming Wegovy heart health study

The high cost of giving birth even with insurance

Microbiome research is starting to find links to chronic diseases

leisure time

CDC advisers recommend seasonal use of Pfizer RSV shot

Intarcia’s device

US intelligence assessment says Iran not currently developing nuclear weapons

What are cluster munitions? Biden defends decision to send controversial weapons to Ukraine

AstraZeneca, Daiichi breast cancer treatment succeeds in trial

What Congress can do to address the rural doctor shortage

Wikipedia

knowledge

knowledge

hotspot